BIOMAT Database Logo BIOMAT Database Logo

[Recent advances in the therapy of the Parkinsonian syndrome]. 1976

L Lombardo

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson

Related Publications

L Lombardo
Recent advances in atypical parkinsonian disorders.
August 1999, Current opinion in neurology,
L Lombardo
Anticoagulation therapy in the antiphospholipid syndrome: recent advances.
September 2005, Current opinion in pulmonary medicine,
L Lombardo
Recent advances in the therapy of Stokes-Adams syndrome.
July 1960, Delaware state medical journal,
L Lombardo
[Kawasaki's syndrome: recent advances in diagnosis and therapy].
September 2010, Recenti progressi in medicina,
L Lombardo
Recent advances in the diagnosis and therapy of Richter's syndrome.
January 2007, Medical oncology (Northwood, London, England),
L Lombardo
[Recent advances in therapy for nephrotic syndrome in children].
January 2007, Nihon Jinzo Gakkai shi,
L Lombardo
[The therapy of the parkinsonian syndrome].
February 1999, Deutsche medizinische Wochenschrift (1946),
L Lombardo
[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance].
January 2006, Therapie,
L Lombardo
Recent advances in antithrombotic therapy after acute coronary syndrome.
May 2014, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
L Lombardo
Recent advances in therapy.
October 1952, Bulletin of the School of Medicine (Baltimore, Md.),
Copied contents to your clipboard!